- Home
- NRXS vs SANW Comparison
NRXS vs SANW Comparison
Compare NRXS & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- SANW
- Stock Information
- Founded
- NRXS 2011
- SANW 1980
- Country
- NRXS United States
- SANW United States
- Employees
- NRXS N/A
- SANW N/A
- Industry
- NRXS
- SANW Farming/Seeds/Milling
- Sector
- NRXS
- SANW Consumer Staples
- Exchange
- NRXS Nasdaq
- SANW Nasdaq
- Market Cap
- NRXS 17.8M
- SANW 18.8M
- IPO Year
- NRXS 2023
- SANW 2010
- Fundamental
- Price
- NRXS $2.31
- SANW $7.50
- Analyst Decision
- NRXS
- SANW Strong Buy
- Analyst Count
- NRXS 0
- SANW 1
- Target Price
- NRXS N/A
- SANW $35.00
- AVG Volume (30 Days)
- NRXS 22.4K
- SANW 8.3K
- Earning Date
- NRXS 04-08-2025
- SANW 02-13-2025
- Dividend Yield
- NRXS N/A
- SANW N/A
- EPS Growth
- NRXS N/A
- SANW N/A
- EPS
- NRXS N/A
- SANW N/A
- Revenue
- NRXS $2,456,219.00
- SANW $54,809,365.00
- Revenue This Year
- NRXS $383.16
- SANW N/A
- Revenue Next Year
- NRXS N/A
- SANW $9.92
- P/E Ratio
- NRXS N/A
- SANW N/A
- Revenue Growth
- NRXS N/A
- SANW N/A
- 52 Week Low
- NRXS $2.05
- SANW $2.10
- 52 Week High
- NRXS $3.78
- SANW $13.49
- Technical
- Relative Strength Index (RSI)
- NRXS 38.24
- SANW 37.23
- Support Level
- NRXS $2.39
- SANW $7.10
- Resistance Level
- NRXS $2.51
- SANW $8.10
- Average True Range (ATR)
- NRXS 0.15
- SANW 0.65
- MACD
- NRXS -0.03
- SANW -0.25
- Stochastic Oscillator
- NRXS 7.14
- SANW 15.33
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.